These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 17001767)

  • 21. GMPs vs GCPs: manufacturing and compounding definitions.
    Allen LV
    Int J Pharm Compd; 2013; 17(5):356. PubMed ID: 24459778
    [No Abstract]   [Full Text] [Related]  

  • 22. Continuous manufacturing and process analytical tools.
    Maniruzzaman M; Douroumis D
    Int J Pharm; 2015 Dec; 496(1):1-2. PubMed ID: 26647292
    [No Abstract]   [Full Text] [Related]  

  • 23. Response.
    Guharoy R; Noviasky J; Haydar Z; Fakih MG; Hartman C
    Chest; 2013 Aug; 144(2):717-718. PubMed ID: 23918133
    [No Abstract]   [Full Text] [Related]  

  • 24. When pharmacies cause harm.
    Jha VM
    Chest; 2013 Aug; 144(2):717. PubMed ID: 23918132
    [No Abstract]   [Full Text] [Related]  

  • 25. PreScription: Drug Quality and Security Act Implementation Subcommittee Hearing.
    Allen LV
    Int J Pharm Compd; 2018; 22(2):92. PubMed ID: 29877856
    [No Abstract]   [Full Text] [Related]  

  • 26. Problems Associated With Some Drug Formulations.
    Paul Y
    Indian Pediatr; 2019 Jun; 56(6):513-514. PubMed ID: 31278243
    [No Abstract]   [Full Text] [Related]  

  • 27. Biopharmaceutical benchmarks--2003.
    Walsh G
    Nat Biotechnol; 2003 Aug; 21(8):865-70. PubMed ID: 12894198
    [No Abstract]   [Full Text] [Related]  

  • 28. GMPs vs GCPs: United States Pharmacopeia General Chapters.
    Allen LV
    Int J Pharm Compd; 2013; 17(5):439. PubMed ID: 24459791
    [No Abstract]   [Full Text] [Related]  

  • 29. Radiopharmaceutical production--radiation safety.
    Fredrickson RL; Myers CB
    IMS Ind Med Surg; 1969 Jul; 38(7):199-204. PubMed ID: 5256328
    [No Abstract]   [Full Text] [Related]  

  • 30. [Medicines raw materials used in compounding medicines: an update of the legislation].
    Huyghebaert C; Leuckx S
    J Pharm Belg; 2010 Mar; (1):16-8. PubMed ID: 20429391
    [No Abstract]   [Full Text] [Related]  

  • 31. Anesthesia Medication Handling Needs a New Vision.
    Grigg EB; Roesler A
    Anesth Analg; 2018 Jan; 126(1):346-350. PubMed ID: 29189282
    [No Abstract]   [Full Text] [Related]  

  • 32. Pfizer and its competitive marketing challenges.
    Carter T
    J Hosp Mark Public Relations; 2003; 14(2):85-97. PubMed ID: 14753324
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current good manufacturing practices for PET drug products in the United States.
    Swanson D; Graham M; Heinonen TM; Libby P; Mills GQ
    J Nucl Med; 2009 Aug; 50(8):26N-8N. PubMed ID: 19652213
    [No Abstract]   [Full Text] [Related]  

  • 34. Quality control in manufacturing process by near infrared spectroscopy.
    González F; Pous R
    J Pharm Biomed Anal; 1995 Apr; 13(4-5):419-23. PubMed ID: 9696551
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Costs of quality in the production process of drugs].
    Klantschnigg P
    Boll Chim Farm; 1979 Jan; 118(1):1-8. PubMed ID: 454525
    [No Abstract]   [Full Text] [Related]  

  • 36. [Production and control in the pharmaceutical industry. Treatment of initial substances and materials. Requirements of the iks (intercantonal control agency) guide lines].
    Zinn W
    Pharm Acta Helv; 1973 Jan; 48(1):1-21. PubMed ID: 4696262
    [No Abstract]   [Full Text] [Related]  

  • 37. Disinfectants as an aid for good manufacturing practice in the pharmaceutical industry.
    Wallhäusser KH
    J Pharm Belg; 1981; 36(5):283-97. PubMed ID: 7310623
    [No Abstract]   [Full Text] [Related]  

  • 38. [Various aspects of the significance of government control in drug supply].
    Teijgeler CA; Samsom RJ
    Pharm Weekbl; 1969 Jun; 104(26):539-49. PubMed ID: 5788999
    [No Abstract]   [Full Text] [Related]  

  • 39. [Production and control in the pharmaceutical industry. Treatment of initial substances and materials. Organization and practice in larger plants].
    Büchler W
    Pharm Acta Helv; 1973 Jan; 48(1):11-21. PubMed ID: 4696261
    [No Abstract]   [Full Text] [Related]  

  • 40. [Production and control in the pharmaceutical industry. Treatment of initial substances and materials. Organization and practice in medium-size plants].
    Schlumpf R
    Pharm Acta Helv; 1973 Jan; 48(1):22-36. PubMed ID: 4696263
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.